A Phase 1 Double-Blind, Randomised, Two-Treatment Cross-over Study Comparing the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PF530 and Betaferon Administered by Subcutaneous Injection in Healthy Adult Volunteers
Phase of Trial: Phase I
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Interferon beta-1b (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- Sponsors Pfenex
- 07 Jun 2017 Biomarkers information updated
- 13 Nov 2015 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 18 Jun 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.